Attached files
| file | filename |
|---|---|
| 8-K/A - Enveric Biosciences, Inc. | form8-ka.htm |
Exhibit 16.1
June 29, 2021
Office
of the Chief Accountant
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Ladies and Gentlemen:
We have read the statements made by Enveric Biosciences, Inc. under Item 4.01 of its Form 8-K/A filed on June 29, 2021. We agree with the statements concerning our Firm under Item 4.01; we are not in a position to agree or disagree with other statements contained therein.
| Very truly yours, | |
| /s/ Marcum LLP |